Cannabinoid Deficiency or Clinical Endocannabinoid Deficiency Syndrome.
The clinical definition of Clinical Endocannabinoid Deficiency Syndrome is the body’s lack of ability to produce a significant amount of cannabinoids by itself.
The body naturally produces neuromodulatory lipids called endocannabinoids, which interact cannabinoid receptors throughout the body to elicit chemical responses that keep the body in balance.EchoConnection.org – https://echoconnection.org/clinical-endocannabinoid-deficiency/
The theory of clinical endocannabinoid deficiency suggests that in some cases the body doesn’t produce enough endocannabinoids or enough receptors for the endocannabinoid system to function properly. As a result, the many functions aren’t regulated properly and the body becomes unbalanced, allowing diseases to arise.
Who has an Endocannabinoid System (ECS)?
The Endocannabinoid System is present in all beings that have vertebrate or a nervous system. This applies to a large majority of creatures and all of humanity.
The clinical cannabinoid deficiency is what happens when a person’s body does not have the ability to naturally produce the cannabinoids it needs to allow the Endocannabinoid System to operate efficiently.
People who have a compromised endocannabinoid system may be subject to experience:
- Migraine Headaches
- IBS (Irritable Bowel Syndrome)
- Inflammatory Pain
- Many others..
It is a common thought that this could be the cause for a wide variety of what we currently call diseases, such as: fibromyalgia, irritable bowel syndrome, and many other “treatment-resistant conditions”
The Study: CEDS
You can review this early case study thanks to the National Institute of Health – The Clinical Endocannabinoid Deficiency Syndrome
Cannabinoid & Terpene Profiles
When you really look at all of the known benefits of Cannabinoids and Terpenes , it begins to reveal how such a broad spectrum of benefits directly co-relates to these currently known treatment resistant diseases.
Found on: BeyondTHC.com
Found On: BuyTerpenes.com
Found on: CannaInsider.com
In fact, it very well could mean that treatment resistant diseases are actually symptoms of Cannabinoid Deficiency.
What you need to know about CEDS
Clinical Endocannabinoid Deficiency Syndrome is likely a major factor in many of our health issues, and more of us may suffer from it than originally thought.
The good news is that these individuals with this condition or these symptoms, now more than ever, have an opportunity to explore cannabinoids and their effects on them.
How to get started with Cannabinoids
If you have not already looked into hemp or cannabis CBD products, you may want to start there! Some people will benefit more from one than the other, but the real difference is in the cannabinoid presence itself, and the balances they need to perform tasks.
Because this field is so new, it’s impossible (or at least highly presumptuous) to directly tell anyone that any cannabinoids will do something for anyone with X condition.
This is because of what is called the Ensemble Effect (or Entourage Effect for others understanding.)
I’ve never used cannabinoids before
If you’re new to cannabinoids, it’s important to educate yourself on what the endocannabinoid system is first.
Next, you will want to understand what drugs interact with cannabinoids.
Finally, if you’ve never taken an oil sub-lingually, follow our Heartland CBD’s getting started guide.
Hemp is useless, Cannabis is better.
You may find some rhetoric on the internet claiming that hemp does not have the same cannabinoids as cannabis. This is not true at all.
If you have heard this, and haven’t looked at the similarities and differences between hemp and cannabis, please read this article.
Omega-3 and Pregnancy According to the National Institute of Health in a study conducted in 2008, pregnant women are not…Read More
EVIO Labs Florida Expands Testing Capabilities with the support of Shimadzu Scientific Instruments EVIO FLORIDA EQUIPPED TO HANDLE UPWARDS OF…Read More
Recently while reading the latest edition of Marijuana Business Magazine published in August 2018, I found bias and rhetoric being…Read More